Alhajahjeh, A.; Al-Faouri, R.; Bahmad, H.F.; Bader, T.; Dobbs, R.W.; Abdulelah, A.A.; Abou-Kheir, W.; Davicioni, E.; Lee, D.I.; Shahait, M.
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer. Cancers 2024, 16, 1538.
https://doi.org/10.3390/cancers16081538
AMA Style
Alhajahjeh A, Al-Faouri R, Bahmad HF, Bader T, Dobbs RW, Abdulelah AA, Abou-Kheir W, Davicioni E, Lee DI, Shahait M.
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer. Cancers. 2024; 16(8):1538.
https://doi.org/10.3390/cancers16081538
Chicago/Turabian Style
Alhajahjeh, Abdulrahman, Raad Al-Faouri, Hisham F. Bahmad, Taima’ Bader, Ryan W. Dobbs, Ahmed A. Abdulelah, Wassim Abou-Kheir, Elai Davicioni, David I. Lee, and Mohammed Shahait.
2024. "From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer" Cancers 16, no. 8: 1538.
https://doi.org/10.3390/cancers16081538
APA Style
Alhajahjeh, A., Al-Faouri, R., Bahmad, H. F., Bader, T., Dobbs, R. W., Abdulelah, A. A., Abou-Kheir, W., Davicioni, E., Lee, D. I., & Shahait, M.
(2024). From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer. Cancers, 16(8), 1538.
https://doi.org/10.3390/cancers16081538
